Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/14/2008

1,373,096 1,426,271

Amortization 140,911 117,830

Interest income (92,523) (935,932)

(Gain) on sale of assets (8,554) --

(Increase) decrease in assets:

Accounts receivable, trade -

related parties (15,693,689) (4,062,388)

Accounts receivable, trade -

third parties 22,722 --

Other receivables 498,556 2,239,427

Other receivables - related

parties (526,327) (4,120,698)

Inventories 190,894 1,628,894

Employee advances (185,415) (49,889)

Prepaid expense 365,778 406,509

Increase (decrease) in liabilities:

Accounts payable 1,223,358 (648,583)

Advances from customers - related

parties 663,444 (67,035)

Wages and benefits payable (422,254) (289,033)

Other taxes payable 1,205,680 (40,345)

Other payables (67,118) (83,390)

Other payables - related parties 16,388 (299,389)

Net cash provided by operating

activities (1,119,756) 9,858,034

CASH FLOWS FROM INVESTING ACTIVITIES:

Repayment from (loans to) related

parties 2,133,222 (4,689,017)

Collections from loans to local

government 450,197 --

Acquisition of intangible asset
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
2. Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
3. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
4. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. ThirdBiotech Announces Kemeta as Newest Sponsor
7. Yongye Biotechnology International Retains CCG Investor Relations
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A
11. New Book on the Business of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Newswire-FirstCall/ -- ,, 3Q09 Corporate Hig...) E.U. Marketing Authorization to Astellas Pharma ...ial readiness activities Expanded management team...and Director, Commercial Operations Appointed Bra...mmittee chairman , Upcoming 2009 Milestones...
(Date:11/6/2009)...a for Arrowhead’s 2010 Personalized Medicine...ce on February 22-24, 2010 in Philadelphia, has be... highlight key issues in forming partnerships and ...s. , Minneapolis, MN (PRW...squo;s 2010 Personalized Medicine Partnerships Co...
(Date:11/5/2009)...ewswire/ -- DSM Pharmaceutical Products today anno...th Galenix, Saint Jean D,Illac, France, where DSM ...ng partner for Galenix commercial products on a gl... on business development opportunities co-marketin... strength of Galenix in drug product development a...
(Date:11/5/2009)...re-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin ... the quarter ended September 30, 2009. The Company...hat follow. ,, Third Quarter 2009 ,, The C...r share for the third quarter of 2009 as compared ...he third quarter of 2008. ,, Net sales were $5...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...Separate Analysis Suggests Paliperidone ER May Imp...s receiving,paliperidone extended-release tablets ...n the hospital, had significantly fewer emergency ...wer psychotherapy sessions,compared with the year ...ysis of data presented at the 161st Annual Meeting...
...All amounts are in U.S. dollars, QUEBEC CITY, May...(NASDAQ: AEZS , TSX: AEZ), a global biopharmaceut..., today reported financial and operating results,f...t Quarter 2008 Highlights, - Cetrorelix: first pa...Phase 3 program in benign prostatic hyperplasia (B...
..., Carbon nanotubes potential as a super material... often take the form of an unprepossessing pile o...ow researchers in the University of Warwicks Depar...arbon nanotubes in which they instantly form a hig...research has just been published in a paper entitl...
Other Biology Technology:Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources 2Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources 3Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources 4Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources 5Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources 6AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 2AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 3AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 4AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 5AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 6AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 7Nanotube production leaps from sooty mess in test tube to ready formed chemical microsensors 2
(Date:11/6/2009)... 06, 2009) The Monell Center and the Chinese Acad...International Meeting on Taste and Smell Research...., the meeting will be the first international meet...an Leshner, Chief Executive Officer, American Asso...ve Publisher of Science magazine, will open the me...
(Date:11/5/2009)...has been awarded a training grant in the amount of...er its Integrative Graduation Education and Resear...RT grant to be awarded to Kent State. The grant, w...nvestment Act of 2009, runs through 2014. , The ...onment aquatic resource sensing (EARS). The purpos...
(Date:11/4/2009)...s in the cities of Long Beach and Riverside are re...ble childhood asthma, and the true impact of air p...ely been underestimated, according to researchers ..., The study, which appears in an online edition o...ed that nine percent of all childhood asthma cases...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USC study finds big air pollution impacts on local communities 2New Jersey Hospital Protects Patient Safety with Advanced Pharmacy Automation Solution 51167 1New Jersey Hospital Protects Patient Safety with Advanced Pharmacy Automation Solution 51167 2New Jersey Hospital Protects Patient Safety with Advanced Pharmacy Automation Solution 51167 3ONRAD Announces New PACS Application Service Provider Model 51165 1ONRAD Announces New PACS Application Service Provider Model 51165 2Link between migraines and reduced breast cancer risk confirmed in follow up study 51163 1Link between migraines and reduced breast cancer risk confirmed in follow up study 51163 2
...rofessor Mark Pagani in the Department of Geology ...he first detailed history of atmospheric carbon di...table isotopes of carbon in a National Science Fou...ugh the energy we consume, each of us makes a cont...carbon dioxide and methane, in the Earth,s atmosph...
...stricting calories over decades may add a few year... to live to 125 and beyond, as many have speculate...is that suffering years of misery to remain super-...of a longer life," said UCLA evolutionary biologis...estriction may not make you live forever, but it s...
...mediately notice if the outside world suddenly wen...re of our blinks, even though they cause a similar.... So why are we not aware of the frequent mini-bla...s discovered that visual sensitivity begins decrea...hanisms underlying this process have until now rem...
Other Biology News:Invasive parasite destroying fish species 2Caloric restriction won't dramatically extend life span in humans: UCLA research 2Caloric restriction won't dramatically extend life span in humans: UCLA research 3Blink, and the brain misses it 2
Rat TRACP 5b ELISA Kit, TRAPTM from IDS Ltd
...se-digesting enzyme developed by Promega for simpl...rom agarose gels. The enzyme is sufficiently therm...d at 6575C does not have to be equilibrated to the...ace the tube containing the molten agarose at 4247...
Poly A Polymerase from Invitrogen
Hot StarTaq Master Mix Kit from QIAGEN
Biology Products: